chloroquine diphosphate has been researched along with 2019 Novel Coronavirus Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 25 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Ji, X; Liu, Y; Sun, H; Wang, G; Yang, X; Zhang, Y | 1 |
| Fang, S; Hu, S; Huang, C; Liu, H; Qi, W; Qu, J; Wang, G; Zhang, G; Zhao, J | 1 |
| Chen, Y; Luo, F; Wan, D; Wang, X; Xiang, W; Xu, F | 1 |
| Barbosa, LA; Enes, KP; Rocha, GM; Santos, HBD; Silva, IF; Thomé, RG; Varotti, FP | 1 |
| Abiola, A; Adeyemo, WL; Agabi, OP; Aina, OO; Ajibaye, O; Akase, IE; Akinbode, GO; Akintan, PE; Amoo, OS; Audu, RA; Bamidele, TA; Bode, C; Busari, AA; David, AN; Esezobor, C; Ezechi, OC; Fadipe, B; Ima-Edomwonyi, E; James, AB; Musa, AZ; Nmadu, N; Okoyenta, CO; Okwuraiwe, AP; Oladele, DA; Olakiigbe, AK; Olopade, OB; Osuolale, KA; Otrofanowei, E; Raheem, TY; Salako, AO; Salako, BL; Tade, T | 1 |
| Gao, J; Tian, Z; Yang, X | 1 |
| Li, J; Qi, C; Shen, L; Wang, Y; Zhang, Q | 1 |
| Wang, Y; Zhu, LQ | 1 |
| Bradley, SM; Fihn, SD; Perencevich, E | 1 |
| Albuquerque, BC; Alexandre, MAA; Baía-da-Silva, D; Balieiro, AAS; Bassat, Q; Borba, MGS; Brito, M; Brito-Sousa, JD; Croda, J; Daniel-Ribeiro, CT; Fontes, CJ; Guerra, MVF; Hajjar, LA; Lacerda, MVG; Melo, GC; Monteiro, WM; Mourão, MPG; Naveca, FG; Nogueira, ML; Pacheco, AGF; Pinto, RC; Romero, GAS; Sampaio, VS; Santos, JDO; Schwarzbold, A; Siqueira, AM; Val, FFA; Xavier, MS | 1 |
| Ahmad, SI | 1 |
| Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A | 1 |
| Almasri, H; Ata, F; Sajid, J; Yousaf, Z | 1 |
| Cai, C; Deng, Y; Hu, ZY; Huang, K; Huang, Y; Wang, X; Wang, Y; Xie, J; Xie, Y; Xu, D; Zang, J; Zhan, T; Zheng, F | 1 |
| Han, YJ; Ji, XY; Li, XX; Ma, CY; Ren, ZG; Wu, DD; Yan, JL | 1 |
| Mo, L; Zheng, P | 1 |
| Alshaeri, HK; Natto, ZS | 1 |
| Cai, T; Cui, C; Hou, Z; Li, H; Lin, J; Liu, D; Liu, Q; Wang, X; Xiong, Z; Yan, X; Yao, X; Zhang, S | 1 |
| Ciza, P; Hubert, P; Marini, RD; Ngono, R; Sacre, PY; Waffo Tchounga, CA; Ziemons, E | 1 |
| Ilunga, CK; Kongo, RM; Limbole, EB; Massolo, JM; Matangila, JR; Muyembe, BM; Mvwala, RK; Ngoy, CD; Ntalaja, JM; Nyembu, RK; Sakobo, TM; Telo, GM | 1 |
| Ehrlich, H; Elkbuli, A | 1 |
| Cai, L; Cao, Y; Fu, M; Guo, X; Hong, L; Yi, G; Ying, P; Zhang, Y | 1 |
| Cai, T; Fu, L; Hu, Y; Huang, Z; Xiong, Z; Ye, H; Zhang, S; Zheng, N; Zhu, H | 1 |
| Beck-Friis, J; Gisslen, M; Leach, S; Omerovic, E; Yilmaz, A; Zeijlon, R | 1 |
6 review(s) available for chloroquine diphosphate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Clinical trial analysis of 2019-nCoV therapy registered in China.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Disease Management; Disease Outbreaks; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Pyrazines; SARS-CoV-2 | 2020 |
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.
Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome | 2020 |
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome | 2020 |
Advances and challenges in the prevention and treatment of COVID-19.
Topics: Amides; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Chloroquine; Chlorpromazine; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclophilins; Drug Development; Drug Repositioning; Drugs, Chinese Herbal; Endocytosis; Humans; Immune Sera; Interferon Inducers; Nucleic Acid Synthesis Inhibitors; Pandemics; Pneumonia, Viral; Pyrazines; Resveratrol; SARS-CoV-2; Viral Vaccines | 2020 |
A contemporary look at COVID-19 medications: available and potentially effective drugs.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Imatinib Mesylate; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients.
Topics: Administration, Oral; Adult; Aged; Chloroquine; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Repositioning; Female; Gastrointestinal Absorption; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; SARS-CoV-2 | 2021 |
3 trial(s) available for chloroquine diphosphate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in Nigeria.
Topics: Adult; Chloroquine; COVID-19; Humans; Hydroxychloroquine; Middle Aged; Nigeria; SARS-CoV-2; Treatment Outcome | 2023 |
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Brazil; Chloroquine; Coronavirus Infections; COVID-19; Disease Outbreaks; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tertiary Care Centers | 2020 |
[Chloroquine phosphate: therapeutic drug for COVID-19].
Topics: Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
16 other study(ies) available for chloroquine diphosphate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Removal Performance and Mechanism of Emerging Pollutant Chloroquine Phosphate from Water by Iron and Magnesium Co-Modified Rape Straw Biochar.
Topics: Adsorption; Charcoal; COVID-19; COVID-19 Drug Treatment; Environmental Pollutants; Humans; Iron; Kinetics; Magnesium; Water; Water Pollutants, Chemical | 2023 |
Toxicity Evaluation and Effect-Based Identification of Chlorine Disinfection Products of the Anti-COVID-19 Drug Chloroquine Phosphate.
Topics: Animals; Chlorine; COVID-19; COVID-19 Drug Treatment; Disinfection; Water; Water Pollutants, Chemical; Zebrafish | 2023 |
Mechanistic investigation of direct photodegradation of chloroquine phosphate under simulated sunlight.
Topics: COVID-19; COVID-19 Drug Treatment; Humans; Kinetics; Photolysis; Sunlight; Water Pollutants, Chemical | 2023 |
Toxicological effects of hydroxychloroquine sulfate and chloroquine diphosphate substances on the early-life stages of fish in the COVID-19 pandemic context.
Topics: Animals; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Larva; Pandemics; Zebrafish | 2023 |
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
Topics: Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Multicenter Studies as Topic; Pneumonia, Viral; SARS-CoV-2 | 2020 |
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
Topics: Anti-Inflammatory Agents, Non-Steroidal; China; Chloroquine; Consensus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Humans; Length of Stay; Pneumonia, Viral; Practice Guidelines as Topic | 2020 |
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.
Topics: Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus | 2020 |
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deoxyribonucleosides; Deoxyribose; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Inflammation; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
COVID-19 presenting with diarrhoea and hyponatraemia.
Topics: Abdominal Pain; Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Darunavir; Diagnosis, Differential; Diarrhea; Humans; Hyponatremia; Male; Pandemics; Pneumonia, Viral; Ribavirin; SARS-CoV-2; Treatment Outcome | 2020 |
Treatment strategies of hospitalized patients with coronavirus disease-19.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Female; gamma-Globulins; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Indoles; Interferons; Lopinavir; Male; Middle Aged; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2 | 2020 |
Composition analysis of falsified chloroquine phosphate samples seized during the COVID-19 pandemic.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Chloroquine; Chromatography, High Pressure Liquid; Counterfeit Drugs; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Spectrum Analysis, Raman; Tablets | 2021 |
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
Topics: Adult; Aged; Blood Coagulation; Chloroquine; Coinfection; Comorbidity; Cough; COVID-19; COVID-19 Drug Treatment; Democratic Republic of the Congo; Female; Fever; Hospitalization; Hospitals, Public; Humans; Hydroxychloroquine; Inflammation; Liver Function Tests; Malaria; Male; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors; Social Class; Tachycardia | 2020 |
Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
Topics: Angiotensin-Converting Enzyme 2; Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Cardiovascular Diseases; Chloroquine; Comorbidity; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Humans; Hydroxychloroquine; Long QT Syndrome; Myocytes, Cardiac; Receptors, Coronavirus; SARS-CoV-2; Torsades de Pointes | 2021 |
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review).
Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Cardiovascular Diseases; Chloroquine; COVID-19; Host-Pathogen Interactions; Humans; Indoles; Molecular Targeted Therapy; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization | 2021 |
Risk factors for prolonged virus shedding of respiratory tract and fecal in adults with severe acute respiratory syndrome coronavirus-2 infection.
Topics: Adult; Animals; Antiviral Agents; CD4 Lymphocyte Count; Chloroquine; COVID-19; Feces; Female; Humans; Killer Cells, Natural; Longitudinal Studies; Lopinavir; Lynx; Male; Obesity; Respiratory System; Retrospective Studies; Risk Factors; Ritonavir; SARS-CoV-2; Time Factors; Virus Shedding | 2021 |
No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
Topics: Aged; Antiviral Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Chloroquine; COVID-19; COVID-19 Drug Treatment; Creatinine; Electrocardiography; Female; Heart Failure; Heart Injuries; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Troponin T | 2021 |